Literature DB >> 26613119

Natural products, micronutrients, and nutraceuticals for the treatment of depression: A short review.

Seyed Mohammad Nabavi1, Maria Daglia2, Nady Braidy3, Seyed Fazel Nabavi1.   

Abstract

OBJECTIVES: Depression is one of the most common psychiatric disorders, and the fourth leading cause of long-term disability throughout the world. Despite the availability of different classes of antidepressant drugs, most of them are not completely effective and above all are associated with many serious adverse effects. Recently, accumulating evidence suggests that dietary supplements rich in important phytochemicals possess beneficial therapeutic roles in depression.
METHODS: In this review, we will first consider what is known about the pathogenesis of depression and discuss the need for more safe and efficacious treatment. We will then review the potential clinical relevance of natural plant-derived products based on data derived from pre-clinical animal studies, randomized controlled studies and placebo-controlled trials published on this topic within the last decade.
RESULTS: Among the natural compounds that show antidepressive-like activity, green tea catechins have been shown to decrease depressive symptoms in experimental animals, possibly in part through the inhibition of monoamine oxidase (MAO). Anthocyanins and their aglycons, responsible for the typical color of berries, inhibit MAO isoforms A or B with IC50 values corresponding to the micromolar range. Other studies suggest that cocoa extracts, whose main components are procyanidins, attenuate depressive symptoms in rats. Resveratrol, one of the most important natural stilbenoid, inhibits noradrenaline and serotonin reuptake in rats, and significantly decreases anxiety/depressive behaviours while increasing hippocampal serotonin and noradrenaline levels. Trans-resveratrol possesses MAO-A inhibitory effects in different brain areas, particularly in the frontal cortex and hippocampus, as already reported for tea catechins. Although these effects have been documented in rodent models, further randomized controlled trials in this area are warranted. However, so far, there is only correlative evidence between certain nutrients, such as omega-3 polyunsaturated fatty acids and B vitamins, and depression in human population studies. DISCUSSION: Growing evidence suggests that consumption of these compounds may represent an alternative strategy to delay the onset and progression of depression, and depressive-like symptoms. However, further randomized and placebo-controlled trials are necessary to confirm the potential of these compounds as a possible remedy for this debilitating disorder.

Entities:  

Keywords:  Antidepressants; Depression; Flavonoids; Natural products; Polyphenols

Mesh:

Substances:

Year:  2015        PMID: 26613119     DOI: 10.1080/1028415X.2015.1103461

Source DB:  PubMed          Journal:  Nutr Neurosci        ISSN: 1028-415X            Impact factor:   4.994


  23 in total

1.  Combined actions of blueberry extract and lithium on neurochemical changes observed in an experimental model of mania: exploiting possible synergistic effects.

Authors:  Luiza Spohr; Mayara Sandrielly Pereira Soares; Pathise Souto Oliveira; Bruna da Silveira de Mattos; Natália Pontes Bona; Nathalia Stark Pedra; Fernanda Cardoso Teixeira; Carlus Augustu Tavares do Couto; Vitor Clasen Chaves; Flávio Henrique Reginatto; Meibel Teixeira Lisboa; Anderson Schwingel Ribeiro; Claiton Leoneti Lencina; Francieli Moro Stefanello; Roselia Maria Spanevello
Journal:  Metab Brain Dis       Date:  2018-12-07       Impact factor: 3.584

2.  Improvement of Antioxidant Defences and Mood Status by Oral GABA Tea Administration in a Mouse Model of Post-Stroke Depression.

Authors:  Maria Daglia; Arianna Di Lorenzo; Seyed Fazel Nabavi; Antoni Sureda; Sedigheh Khanjani; Akbar Hajizadeh Moghaddam; Nady Braidy; Seyed Mohammad Nabavi
Journal:  Nutrients       Date:  2017-04-29       Impact factor: 5.717

3.  MicroRNA-27a participates in the pathological process of depression in rats by regulating VEGFA.

Authors:  Jian Cui; Cunqi Gong; Baorui Cao; Longfei Li
Journal:  Exp Ther Med       Date:  2018-03-09       Impact factor: 2.447

4.  Analysis of the pharmacological mechanism of Banxia Xiexin decoction in treating depression and ulcerative colitis based on a biological network module.

Authors:  Ying Yu; Gong Zhang; Tao Han; Hailiang Huang
Journal:  BMC Complement Med Ther       Date:  2020-06-29

Review 5.  Resveratrol and Depression in Animal Models: A Systematic Review of the Biological Mechanisms.

Authors:  Alyssa Moore; Joshua Beidler; Mee Young Hong
Journal:  Molecules       Date:  2018-08-30       Impact factor: 4.411

6.  POSSIBLE EFFECTS OF NUTRACEUTICALS IN THE MANAGEMENT OF SOME NEURODEVELOPMENTAL DISORDERS IN NIGERIAN CHILDREN.

Authors:  A D Ajibade
Journal:  Ann Ib Postgrad Med       Date:  2018-12

7.  Dietary total antioxidant capacity as a preventive factor against depression in climacteric women.

Authors:  Natiani Gonçalves de Oliveira; Iranice Taís Teixeira; Heloísa Theodoro; Catia Santos Branco
Journal:  Dement Neuropsychol       Date:  2019 Jul-Sep

8.  Rutin via Increase in the CA3 Diameter of the Hippocampus Exerted Antidepressant-Like Effect in Mouse Model of Maternal Separation Stress: Possible Involvement of NMDA Receptors.

Authors:  Maryam Anjomshoa; Shakiba Nasiri Boroujeni; Sorayya Ghasemi; Zahra Lorigooini; Ahmad Amiri; Shima Balali-Dehkordi; Hossein Amini-Khoei
Journal:  Behav Neurol       Date:  2020-06-07       Impact factor: 3.342

9.  Investigating the basis for the antidepressant effects of Gleditsiae spina using an integrated metabolomic strategy.

Authors:  Tong Liu; Ning Zhou; Yangang Cao; Ruihao Xu; Zhen Liu; Xiaoke Zheng; Weisheng Feng
Journal:  Iran J Basic Med Sci       Date:  2021-04       Impact factor: 2.699

Review 10.  Inflamed brain: Targeting immune changes and inflammation for treatment of depression.

Authors:  Shinji Sakamoto; Xiaolei Zhu; Yuto Hasegawa; Sadik Karma; Mizuho Obayashi; Emily Alway; Atsushi Kamiya
Journal:  Psychiatry Clin Neurosci       Date:  2021-07-28       Impact factor: 12.145

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.